GEHC Q1 2026 Earnings Profit Misses Estimates Amid Operational Headwinds NOV Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress CAVA Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Performance AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment FITBO Q1 2026 Earnings Earnings Surpass Estimates by 35